NCT01986517

Brief Summary

The purpose of the current study is to examine the influence of feedback on psychotherapeutic competency. The present randomized controlled study compares a feedback condition with a non-feedback condition. Therapists in the feedback condition receive feedback after every fourth session. The feedback is given by two trained and independent raters. The raters are licenced and experienced psychotherapists. Therapists in the non-feedback condition receive no feedback during the psychotherapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

November 11, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 18, 2013

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
Last Updated

March 20, 2015

Status Verified

March 1, 2015

Enrollment Period

1.3 years

First QC Date

November 11, 2013

Last Update Submit

March 19, 2015

Conditions

Mental Disorders

Keywords

FeedbackTherapeutic competenciesTraining

Outcome Measures

Primary Outcomes (1)

  • Cognitive Therapy Scale (CTS)

    external-assessment measure that assesses psychotherapeutic competency during a cognitive therapy session. CTS will be used by two trained raters licensed as psychological psychotherapists.

    participants will be followed for the duration of psychotherapy, an expected average of 20 weeks

Secondary Outcomes (12)

  • Helping Alliance Questionaire (HAQ)

    participants will be followed for the duration of psychotherapy, an expected average of 20 weeks

  • Berner Stundenbögen Version 2000

    participants will be followed for the duration of psychotherapy, an expected average of 20 weeks

  • Global Assessment of Functioning (GAF)

    participants will be followed for the duration of psychotherapy, an expected average of 20 weeks

  • Supervisory Questionaire (SQ)

    participants will be followed for the duration of psychotherapy, an expected average of 20 weeks

  • Supervisee Levels Questionaire (SLQ-R)

    participants will be followed for the duration of psychotherapy, an expected average of 20 weeks

  • +7 more secondary outcomes

Study Arms (2)

Feedback

EXPERIMENTAL

Therapists assigned to this group will receive standardized feedback on their psychotherapeutic competency after every fourth treatment session with a patient for a period of 20 therapy sessions. The feedback will be given by two experienced raters who are licensed as psychological psychotherapists.

Behavioral: Feedback after every fourth session

No feedback

EXPERIMENTAL

Therapists assigned to this group will receive no feedback

Behavioral: No feedback

Interventions

No feedbackBEHAVIORAL

Therapists will receive no feedback.

No feedback
Feedback after every fourth sessionBEHAVIORAL
Feedback

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having successfully completed the interim audit
  • Having started to treat ambulant patients
  • Remaining at least 6 month in the ambulance

You may not qualify if:

  • Patients
  • Meeting ICD 10 criteria for a mental disorder
  • Informed consent
  • Currently in psychotherapy
  • Suicidal tendency
  • Clinical diagnosis of alcohol or drug addiction, acute schizophrenia, schizoaffective disorder or bipolar disorder
  • Clinical diagnosis of personality disorder cluster A (odd disorders) and B (dramatic, emotional or erratic)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Clinical Psychology and Psychotherapy of Goethe University

Frankfurt am Main, Hesse, 60486, Germany

Location

MeSH Terms

Conditions

Mental Disorders

Study Officials

  • Florian Weck, PhD

    Goethe University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

November 11, 2013

First Posted

November 18, 2013

Study Start

November 1, 2013

Primary Completion

March 1, 2015

Study Completion

March 1, 2015

Last Updated

March 20, 2015

Record last verified: 2015-03

Locations

DE(1)